Information on this site is not intended as medical advice and should not be used as a substitute for consulting with a qualified doctor.

Xofluza is an antiviral medicine for treating and preventing flu in adults and children from 1 year of age. The active substance in Xofluza, baloxavir marboxil, blocks an enzyme known as CEN (cap-dependent endonuclease), which the influenza virus uses to produce more copies of itself. By interfering with the activity of this enzyme, the medicine can treat the infection and prevent infection in patients exposed to the virus.

In Bangladesh Xofluza is approved for the following indications.2

Treatment of Influenza

  • XOFLUZA is indicated for the treatment of influenza in patients aged 1 year and above who have been symptomatic for no more than 48 hours (see section 3.1.2 Clinical/ Efficacy Studies).

  • XOFLUZA is indicated for treatment of influenza in patients aged 12 years and above who have been symptomatic for no more than 48 hours, and are at high risk of developing influenza complications.

Post-Exposure Prophylaxis of Influenza

XOFLUZA is indicated for the post-exposure prophylaxis of influenza in individuals aged 1 year and above.

For more disease and medicine related queries you may discuss with your physician.

In Bangladesh Xofluza is available as

Tablets 40 mg


is the authorized importer and distributor for Roche pharmaceutical medicines in Bangladesh. To meet strict quality and compliance, Radiant maintains temperature controlled supply chain.

To ensure patient safety and quality, it is strongly recommended to verify that, each medicine comes with the Roche Hologram Sticker, DGDA approved DAR (Drug Administration Registration) Number imprinted on it. Neither Radiant nor Roche Bangladesh takes liability of any other sources of products.

References

  1. Xofluza | European Medicines Agency [Internet; cited 2023, August 07]. Retrieved from:

  2. xofluza-product-information-ro-7191686-november-2022

This website contains information which is targeted to the people of Bangladesh and could contain product details or information otherwise not accessible or valid in your country. Roche Bangladesh is not responsible for accessing such information that may not be in accordance with legal, regulatory, registration or use processes in your home country. Please note that, information on this site is not intended as medical advice and should not be used as a substitute for consulting with qualified doctor. We are unable to answer questions on individual disease treatment/ management matters. These should be discussed with your physician. We cannot answer product-related questions through this website. Nor this site acts as promotional/ commercial tool for products. It is not permissible to take the contents of this site and use it for commercial purpose, without written consent of Roche Bangladesh.